Bucladesine

CAS: 362-74-3

Ref. TM-T20214

Información del producto

• Nombre: Bucladesine
• Sinónimos: DT 5621, DBC-AMP, Bucladesina, Actosin, (4aR,7R,7aR)-6-[6-(butanoylamino)-9H-purin-9-yl]-2-hydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl butanoate, 3',5'-Cyclic AMP dibutyrate, 3′,5′-Cyclic AMP dibutyrate, 4H-Furo[3,2-d]-1,3,2-dioxaphosphorin, adenosine deriv., 6-[6-(butanoylamino)-9H-purin-9-yl]-2-hydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl butanoate, Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate, Adenosine, N-(1-oxobutyl)-, cyclic 3′,5′-(hydrogen phosphate) 2′-butanoate, Bucladesin, Butyramide, N-(9-β-<span class="text-smallcaps">D</span>-ribofuranosyl-9H-purin-6-yl)-, 2′-butyrate, cyclic 3′,5′-phosphate, Butyramide, N-(9-β-<span class="text-smallcaps">D</span>-ribofuranosyl-9H-purin-6-yl)-, cyclic 3′,5′-(hydrogen phosphate) 2′-butyrate, Butyramide, N-(9-β-D-ribofuranosyl-9H-purin-6-yl)-, 2'-butyrate, cyclic 3',5'-phosphate, Butyramide, N-(9-β-D-ribofuranosyl-9H-purin-6-yl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butyrate, Cyclic AMP N6,2'-O-dibutyrate, Cyclic AMP N⁶,2′-O-dibutyrate, Cyclic AMP dibutyrate, Cyclic dibutyryl-AMP, Dibutyryl 3',5'-cyclic AMP, Dibutyryl 3',5'-cyclic adenosine monophosphate, Dibutyryl 3′,5′-cyclic AMP, Dibutyryl 3′,5′-cyclic adenosine monophosphate, Dibutyryl adenosine 3',5'-cyclic monophosphate, Dibutyryl cAMP, Dibutyryl cyclic 3',5'-AMP, Dibutyryl cyclic 3',5'-adenylic acid, Dibutyryl cyclic 3′,5′-AMP, Dibutyryl cyclic 3′,5′-adenylic acid, Dibutyryl cyclic AMP, Dibutyryl cyclic adenosine 3',5'-monophosphate, Dibutyryl cyclic adenosine 3′,5′-monophosphate, Dibutyryl cyclic adenosine monophosphate, Dibutyryl-3',5'-AMP, Dibutyryl-3',5'-adenosine monophosphate, Dibutyryl-3′,5′-AMP, Dibutyryl-3′,5′-adenosine monophosphate, Dibutyryladenosine 3',5'-cyclic monophosphate, Dibutyryladenosine 3',5'-cyclic phosphate, Dibutyryladenosine 3',5'-cyclophosphate, Dibutyryladenosine 3',5'-monophosphate, Dibutyryladenosine 3′,5′-cyclic monophosphate, Dibutyryladenosine 3′,5′-cyclic phosphate, Dibutyryladenosine 3′,5′-cyclophosphate, Dibutyryladenosine 3′,5′-monophosphate, Dibutyryladenosine cyclic 3',5'-monophosphate, Dibutyryladenosine cyclic 3′,5′-monophosphate, Dibutyryladenosine cyclic monophosphate, Dt 5621, N-(9-beta-D-Ribofuranosyl-9H-furin-6-yl)-butyramide cyclic 3',5'-(hydrogen phosphate) 2'-butyrate, N-6,O-2'-Dibutyryl adenosine cyclic 3':5'-monophosphate, N-6-2-O-Dibutyryl adenosine-3',5'-monophosphate, N6,2'-Dibutyryladenosine cyclic 3',5'-(hydrogen phosphate), N6,2'-O-Dibutyryl 3',5'-cyclic adenosine monophosphate, N6,2'-O-Dibutyryl cAMP, N6,2'-O-Dibutyryl cyclic 3',5'-AMP, N6,2'-O-Dibutyryl cyclic 3',5'-adenosine monophosphate, N6,2'-O-Dibutyryl cyclic AMP, N6,2'-O-Dibutyryladenosine 3',5'-monophosphate, N6,2'-O-Dibutyryladenosine cyclic 3',5'-monophosphate, N6,2'-O-Dibutyryladenosine cyclic 3',5'-phosphate, N6,O2'-Dibutyryl 3',5'-AMP, N6,O2'-Dibutyryl adenosine 3',5'-cyclic monophosphate, N6,O2'-Dibutyryl adenosine-3',5'-phosphate, N6,O2'-Dibutyryl cyclic 3',5'-AMP, N6,O2'-Dibutyryl cyclic AMP, N6,O2'-Dibutyryl cyclic adenosine 3',5'-monophosphate, N6,O2'-Dibutyryl cyclic adenosine 3',5'-monophosphoric acid, N6,O2'-Dibutyryl cyclic adenosine monophosphate, N6,O2'-Dibutyryl-3',5'-cyclic AMP, N6,O2'-Dibutyryl-cAMP, N6,O2'-Dibutyryladenosine 3',5'-monophosphate, N6,O2'-Dibutyryladenosine cyclic 3',5'-phosphate, N6,O2'-Dibutyrylcyclic adenosine 3',5'-phosphate, N6-2'-O-Dibutyryl-3',5'-AMP, N₆-2′-O-Dibutyryl-3′,5′-AMP, N⁶,2′-Dibutyryladenosine cyclic 3′,5′-(hydrogen phosphate), N⁶,2′-O-Dibutyryl 3′,5′-cyclic adenosine monophosphate, N⁶,2′-O-Dibutyryl cAMP, N⁶,2′-O-Dibutyryl cyclic 3′,5′-AMP, N⁶,2′-O-Dibutyryl cyclic 3′,5′-adenosine monophosphate, N⁶,2′-O-Dibutyryl cyclic AMP, N⁶,2′-O-Dibutyryladenosine 3′,5′-monophosphate, N⁶,2′-O-Dibutyryladenosine cyclic 3′,5′-monophosphate, N⁶,2′-O-Dibutyryladenosine cyclic 3′,5′-phosphate, N⁶,O²′-Dibutyryl 3′,5′-AMP, N⁶,O²′-Dibutyryl adenosine 3′,5′-cyclic monophosphate, N⁶,O²′-Dibutyryl adenosine-3′,5′-phosphate, N⁶,O²′-Dibutyryl cyclic 3′,5′-AMP, N⁶,O²′-Dibutyryl cyclic adenosine monophosphate, N⁶,O²′-Dibutyryl-3′,5′-cyclic AMP, N⁶,O²′-Dibutyrylcyclic adenosine 3′,5′-phosphate, N⁶,O^2′-Dibutyryl cyclic AMP, N⁶,O^2′-Dibutyryl cyclic adenosine 3′,5′-monophosphate, N⁶,O^2′-Dibutyryl cyclic adenosine 3′,5′-monophosphoric acid, N⁶,O^2′-Dibutyryl-cAMP, N⁶,O^2′-Dibutyryladenosine 3′,5′-monophosphate, N⁶,O^2′-Dibutyryladenosine cyclic 3′,5′-phosphate, Nsc 143108, dbcAMP, Butyramide, N-(9-β-D-ribofuranosyl-9H-purin-6-yl)-, cyclic 3′,5′-(hydrogen phosphate) 2′-butyrate, Butyramide, N-(9-β-D-ribofuranosyl-9H-purin-6-yl)-, 2′-butyrate, cyclic 3′,5′-phosphate

Descripción

Bucladesine mimics cAMP, permeates cells, and inhibits phosphodiesterase; used in research.

• Marca: Targetmol

Propiedades químicas

• Peso molecular: 469.39
• Fórmula: C₁₈H₂₄N₅O₈P
• Color/Forma: Solid